A Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention - Related Studies

A Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention

This study has been completed.

Study NCT00097591. Last updated on November 5, 2007. Information provided by Eli Lilly and Company

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Coronary Arteriosclerosis
		Acute Coronary Syndrome

2	Additional conditions recognized in this trial
		Arteriosclerosis
		Coronary Artery Disease
		Syndrome

3	More general conditions related to this trial
		Arterial Occlusive Diseases
		Cardiovascular Diseases
		Coronary Disease
		Disease
		Heart Diseases
		Myocardial Ischemia
		Pathologic Processes
		Vascular Diseases

4	Interventions listed in this trial
		Prasugrel
		Clopidogrel

5	More general drug interventions related to this trial
		Hematologic Agents
		Pharmacologic Actions
		Platelet Aggregation Inhibitors
		Therapeutic Uses

6	Sponsors listed in this trial
		Eli Lilly and Company